Piper Sandler Cuts Aadi Bioscience's Price Target to $5 From $30, Keeps Overweight Rating
-- Price: 2.32, Change: -3.05, Percent Change: -56.80 ...
Source: marketscreener.com
Page 4 - Aadi Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Aadi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Aadi Bioscience Today - Breaking & Trending Today
HC Wainwright Downgrades Aadi Bioscience to Neutral From Buy
-- Price: 2.78, Change: -2.59, Percent Change: -48.23 ...
Source: marketscreener.com
Cancer Player Aadi Bioscience Downgraded: Analyst Highlights 'Worse Than Expected' Response Rates - Aadi Bioscience (NASDAQ:AADI)
Friday, Aadi Bioscience Inc (NASDAQ: AADI) released results from a planned interim analysis on the first third of participants in the ongoing tumor-agnostic PRECISION1 trial of nab-sirolimus in patients with
Source: benzinga.com
Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating Alterations
Interim results from investigator-assessed responses in first 40 patients from TSC1 and TSC2 arms demonstrate sustained tumor reductions in heavily pre-treated population 80 patients now enrolled...
Source: marketscreener.com